WellTheory’s $5 million raise included support from new investors Samsung Next, Opal Ventures and Up2 Fund, as well as existing investors Accel, OVO Fund and BoxGroup. The post WellTheory Secures $5M, Introduces New AI Tools to Support Autoimmune Care appeared first on MedCity News.
[Sponsored] The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times. The post How to Optimize Your Phlebotomy Setup for Efficient Patient Care appeared first on MedCity News.
This volume examines the impact of recent executive actions on federal health communication, along with concerns and stigmas surrounding ADHD diagnoses and treatments, including skepticism about pharmaceutical influence on medication promotion. It also explores distrust in food regulations following the FDA’s ban on Red Dye No. 3.
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently. The post EnsoData Snags $20M to Improve Sleep Disorder Diagnostics appeared first on MedCity News.
FDA approval of Crinetics Pharmaceuticals’ Palsonify makes it the first oral first-line therapy for acromegaly, a rare endocrine disorder. The once-daily pill will compete with blockbuster acromegaly drugs from Novartis and Ipsen that are administered as injections. The post With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen appeared…
A monthly injectable GLP-1 drug from Pfizer’s $10 billion Metsera acquisition is now on track for a Phase 3 program spanning 10 pivotal studies this year. While Pfizer’s pipeline spans internally developed and in-licensed assets for other targets, the pharma company says the Metsera drug is the foundation for its obesity strategy pursuing monotherapies and…
The PTC Therapeutics gene therapy, Kebilidi, treats an enzyme deficiency that affects the body’s ability to produce dopamine, a neurotransmitter important for motor control. FDA approval for the product comes two years after it won its first regulatory approvals in Europe. The post PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly…
Bringing the Tools of Accountable Care to Maternity Care is a Great Idea – But This Sure Ain’t It By VICTORIA ADEWALE & J.D. KLEINKE How desperate are we to find some kind of good news about the sorry state of maternity care in America? To find out, look no further than the current cover…
A new American Medical Association survey found that most physicians remain skeptical that insurers’ recent prior authorization reform commitments will meaningfully reduce delays, administrative burdens or patient harm. The post Only 33% of Physicians Believe Health Plans’ Prior Auth Commitments Will Make a Difference appeared first on MedCity News.
The move will save the behavioral healthcare company about $100 million over the next few years.